Startseite Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormone deficiency in children with congenital growth hormone deficiency
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormone deficiency in children with congenital growth hormone deficiency

  • Himanshu Sharma ORCID logo , Naincy Purwar , Anshul Kumar , Rahul Sahlot , Umesh Garg , Balram Sharma und Sandeep Kumar Mathur EMAIL logo
Veröffentlicht/Copyright: 7. April 2021

Abstract

Objectives

Congenital idiopathic growth hormone deficiency (GHD) is associated with various MRI abnormalities, including sellar and extrasellar abnormalities. However, it remains contentious whether MRI brain findings could provide an additional avenue for precisely predicting the differentiation of GHD based on severity and type {isolated GHD or multiple pituitary hormone deficiencies (MPHD)}. This study aimed to ascertain the abnormality that is the best predictor of severity and type of GHD amongst the different MRI findings.

Methods

We conducted an analytical cross-sectional study, including 100 subjects diagnosed with idiopathic GHD. Patients were grouped into severe GHD, partial GHD, and MPHD and into groups based on the presence of pituitary hypoplasia, extrasellar brain abnormalities (EBA), and presence of ectopic posterior pituitary or pituitary stalk abnormalities (EPP/PSA) or both.

Results

Sixty six percentage of subjects had isolated GHD, 34% had MPHD, 71% had severe GHD, and 29% had partial GHD. Pituitary hypoplasia was the most common finding, observed in 53% of patients, while 23% had EBA, and 25% had EPP/PSA. Pituitary hypoplasia was observed to be the best predictor of severity of GHD with an odds ratio (OR) of 10.8, followed by EPP/PSA (OR=2.8), and EBA was the weakest predictor (OR=1.8). Pituitary hypoplasia was the only finding to predict MPHD (OR=9.2) significantly. On ROC analysis, a Pituitary height SDS of −2.03 had the best detection threshold for both severe GHD and MPHD.

Conclusions

We observed Pituitary hypoplasia to be not only the most frequent MRI abnormality but also the best predictor of severe GHD and MPHD amongst various sellar and extrasellar abnormalities.


Corresponding author: Dr. Sandeep Kumar Mathur, Professor and Head, Department of Endocrinology, S.M.S. Medical College and Hospital, 4th floor, Dhanvantri Building, S.M.S. Hospital, Ashok Nagar, Tonk Road, Jaipur, India, Phone: +919414048666, E-mail:

Acknowledgments

We want to thank the study participants and their families for generously donating their time and information.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study in accordance with the Helsinki declaration.

  5. Ethical approval: The research related to human use has been complied with all relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ Institutional Review Board (office of ethical committee, SMS medical college, Jaipur, India. No. 424/mc/ec).

References

1. Velayutham, K, Sivan Arul Selvan, S, Jeyabalaji, RV, Balaji, S. Prevalence and etiological profile of short stature among school children in a South Indian population. Indian J Endocrinol Metab 2017;21:820–2. https://doi.org/10.4103/ijem.ijem_149_17.Suche in Google Scholar

2. Wales, JK. Evaluation of growth disorders. In: Brook, CG, Clayton, PE, Brown, RS, editors. Brook’s clinical pediatric endocrinology. West Sussex: John Wiley and Sons Ltd; 2009:124–54 pp.10.1002/9781444316728.ch6Suche in Google Scholar

3. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society. J Clin Endocrinol Metab 2000;85:3990–3. https://doi.org/10.1210/jcem.85.11.6984.Suche in Google Scholar

4. Acharya, SV, Gopal, RA, Lila, A, Sanghvi, DS, Menon, PS, Bandgar, TR, et al.. Phenotype and radiological correlation in patients with growth hormone deficiency. Indian J Pediatr 2011;78:49–54. https://doi.org/10.1007/s12098-010-0211-1.Suche in Google Scholar

5. Indian Academy of Pediatrics (IAP). IAP growth charts. [Internet]. [cited 2020 Jul 20]. Available from: https://iapindia.org/iap-growth-charts/.Suche in Google Scholar

6. Khadilkar, V, Yadav, S, Agrawal, KK, Tamboli, S, Banerjee, M, Cherian, A, et al.. Revised IAP growth charts for height, weight, and body mass index for 5- to 18-year-old Indian children. Indian Pediatr 2015;52:47–55. https://doi.org/10.1007/s13312-015-0566-5.Suche in Google Scholar

7. Grimberg, A, DiVall, SA, Polychronakos, C, Allen, DB, Cohen, LE, Quintos, JB, et al.. Guidelines for growth hormone and insulin-like growth factor-i treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr 2017;86:361–97.10.1159/000452150Suche in Google Scholar

8. Zimmermann, A, Schenk, JP, Sido, PG, Pfäffle, R, Lazea, C, Zimmermann, T, et al.. MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency - correlation with severity of hypopituitarism. J Pediatr Endocrinol Metab 2007;20:587–96. https://doi.org/10.1515/jpem.2007.20.5.587.Suche in Google Scholar

9. Smyczynska, J, Lewinski, A, Hilczer, M, Stawerska, R, Karasek, M. Partial growth hormone deficiency (GHD) in children has more similarities to idiopathic short stature than to severe GHD. Endokrynol Pol 2007;58:182–7.Suche in Google Scholar

10. Singh, A, Kandasamy, D, Garg, A, Jyotsna, V, Khadgawat, R. Study of pituitary morphometry using MRI in Indian subjects. Indian J Endocrinol Metab 2018;22:605. https://doi.org/10.4103/ijem.IJEM_199_18.Suche in Google Scholar

11. Delman, BN. Imaging of pediatric pituitary abnormalities. Endocrinol Metab Clin N Am 2009;38:673–98.10.1016/j.ecl.2009.09.001Suche in Google Scholar

12. Arifa, N, Léger, J, Garel, C, Czernichow, P, Hassan, M. Anomalies malformatives cérébrales associées à l’insuffisance somatotrope chez l’enfant: marqueurs majeurs pour le diagnostic? [Cerebral anomalies associated with growth hormone insufficiency in children: major markers for diagnosis?]. Arch Pediatr 1999;6:14–21. https://doi.org/10.1016/s0929-693x(99)80067-0.Suche in Google Scholar

13. Alba, P, Tsai, S, Mitre, N. The severity of growth hormone deficiency does not predict the presence or absence of brain magnetic resonance imaging abnormalities – a retrospective review. Eur Endocrinol 2020;16:60. https://doi.org/10.17925/ee.2020.16.1.60.Suche in Google Scholar

14. AlJurayyan, RNA, AlJurayyan, NAM, Omer, HG, Alissa, SDA, AlOtaibi, HMN, AlKhalifah, RAH, et al.. Pituitary imaging in 129 children with growth hormone deficiency: a spectrum of findings. Sudan J Paediatr 2017;17:30–5.Suche in Google Scholar

15. Biliaieva, K, Amin, N, Chowdhury, S, Mushtaq, T. Frequency of cranial MRI abnormalities in isolated growth hormone deficiency over a 20-year period. In: Endocrine Abstracts 45th meeting of the British society for paediatric endocrinology and diabetes Newcastle. Bristol: Bioscientifica; 2017, vol. 51:P047 p.10.1530/endoabs.51.P047Suche in Google Scholar

16. Hamilton, J, Blaser, S, Daneman, D. MR imaging in idiopathic growth hormone deficiency. Am J Neuroradiol 1998;19:1609–15.Suche in Google Scholar

17. Cooke, DW, Divall, SA, Radovick, S. Normal, and aberrant growth in children. In: Melmed, S, Auchus, RJ, Goldfine, AB, Koenig, RJ, Rosen, CJ, editors. Williams textbook of endocrinology, 14th ed. Philadelphia: Elsevier; 2019:991–6 pp.10.1016/B978-0-323-29738-7.00024-1Suche in Google Scholar

18. Jagtap, VS, Acharya, SV, Sarathi, V, Lila, AR, Budyal, SR, Kasaliwal, R, et al.. Ectopic posterior pituitary and stalk abnormality predicts severity and coexisting hormone deficiencies in patients with congenital growth hormone deficiency. Pituitary 2012;15:243–50. https://doi.org/10.1007/s11102-011-0321-4.Suche in Google Scholar

19. Bozzola, M, Adamsbaum, C, Biscaldi, I, Zecca, M, Cisternino, M, Genovese, E, et al.. Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency. Clin Endocrinol 1996;45:21–6. https://doi.org/10.1046/j.1365-2265.1996.7570773.x.Suche in Google Scholar

20. Marcu, M, Trivin, C, Souberbielle, J, Brauner, R. Factors influencing the growth hormone peak and plasma insulin-like growth factor I in young adults with pituitary stalk interruption syndrome. BMC Endocr Disord 2008;8:7. https://doi.org/10.1186/1472-6823-8-7.Suche in Google Scholar

21. Tauber, M, Chevrel, J, Diene, G, Moulin, P, Jouret, B, Oliver, I, et al.. Long-term evolution of endocrine disorders and effect of GH therapy in 35 patients with pituitary stalk interruption syndrome. Horm Res 2005;64:266–73. https://doi.org/10.1159/000089425.Suche in Google Scholar

22. Dutta, P, Bhansali, A, Singh, P, Rajput, R, Khandelwal, N, Bhadada, S. Congenital hypopituitarism: clinico-radiological correlation. J Pediatr Endocrinol Metab 2009;22:921–8. https://doi.org/10.1515/jpem.2009.22.10.921.Suche in Google Scholar

Received: 2021-01-22
Accepted: 2021-03-16
Published Online: 2021-04-07
Published in Print: 2021-07-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Delivery factors and neonatal thyroid hormone levels: a systematic review
  4. Original Articles
  5. Birth prevalence of tetrahydrobiopterin deficiency in China: data from the national newborn screening program, 2013–2019
  6. Analysis of the CAG tract length in the Androgen Receptor gene in Mexican patients with nonsyndromic cryptorchidism
  7. Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormone deficiency in children with congenital growth hormone deficiency
  8. Urinary gonadotropin measurements by enhanced luminometric assays (LIA) for the evaluation of pubertal development
  9. Challenges in management of transient hyperinsulinism – a retrospective analysis of 36 severely affected children
  10. Who should return for an oral glucose tolerance test? A proposed clinical pathway based on retrospective analysis of 332 children
  11. Investigation of the prevalence of cardiovascular risk factors in obese patients diagnosed with metabolic syndrome in childhood and examination of left ventricular function by echocardiography
  12. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial
  13. Management of patients with X-linked hypophosphatemic rickets during Covid-19 pandemic lockdown
  14. Evaluation of the pathophysiological role of Fetuin A levels in adolescents with polycystic ovary syndrome
  15. Gonadotropins for testicular descent in cryptorchid congenital hypogonadotropic hypogonadism males beyond infancy
  16. Clinical characteristics and outcome of hospitalized children and adolescent patients with type 1 diabetes during the COVID-19 pandemic: data from a single center surveillance study in Egypt
  17. Letter to the Editor
  18. Revisiting the effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria
  19. Case Reports
  20. Pulmonary and cutaneous mucormycosis in two children with diabetes mellitus type 1
  21. Pyruvate carboxylase deficiency type C as a differential diagnosis of diabetic ketoacidosis
  22. Barth syndrome with severe dilated cardiomyopathy and growth hormone resistance: a case report
  23. The utility of reverse phenotyping: a case of lysinuric protein intolerance presented with childhood osteoporosis
Heruntergeladen am 20.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0049/html
Button zum nach oben scrollen